54 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Blonder Tongue Laboratories, Inc. BDR shares jumped 340.7% to $3.35 after dropping over 4% on Tuesday. Blonder Tongue Laboratories, earlier during the month, reported results for the second quarter.
• Harmony Biosciences Holdings, Inc. HRMY gained 71% to $40.85 after the company priced its upsized initial public offering of 5,348,837 shares at $24.00 per share.
• Allied Esports Entertainment Inc AESE shares surged 70.8% to $2.3050 after the company announced that its Odyssey tournament had roughly 1.6 million live views at over a six-day event.
• Momenta Pharmaceuticals, Inc. MNTA shares climbed 69.3% to $52.17 after Johnson & Johnson announced plans to acquire Momenta Pharmaceuticals for $6.5 billion in cash.
• 9 Meters Biopharma, Inc. NMTR jumped 46.5% to $0.9523 following the company's form 4 filing indicating an insider buy of 100,000 shares. 9 Meters Biopharma shares jumped around 17% on Tuesday after Brookline Capital initiated coverage on the company's stock with a Buy rating and announced a $5 price target.
• Hudson Ltd. HUD shares gained 46.4% to $7.51 after the company reported proposed acquisition of all remaining equity interests in the company for $7.70 per share in cash by Dufry AG Group, Hudson’s controlling shareholder.
• CBL & Associates Properties, Inc. CBL climbed 45.5% to $0.2801 after the company entered into a Restructuring Support Agreement with noteholders to strengthen its capital structures.
• Inhibrx, Inc. INBX rose 37% to $23.29. Inhibrx priced its 7 million share IPO at $17 per share.
• Kirkland's, Inc. KIRK gained 20.9% to $11.48.
• Wah Fu Education Group Limited WAFU shares rose 19.4% to $6.15.
• Ontrak, Inc. OTRK shares gained 17.8% to $63.08.
• GrowGeneration Corp. GRWG rose 17.3% to $20.72 after gaining 9% on Tuesday. GrowGeneration released Q2 results last week.
• iRhythm Technologies, Inc. IRTC jumped 17.2% to $205.48. iRhythm Technologies reported pricing of 1.1 million share upsized public offering of common stock at $175 per share.
• VivoPower International PLC VVPR surged 17% to $3.66 after gaining 16% on Tuesday.
• Everspin Technologies, Inc. MRAM gained 16.5% to $6.27. Everspin, last week, reported Q2 results.
• AutoWeb, Inc. AUTO rose 16.4% to $2.6546.
• Lantern Pharma Inc. LTRN gained 15.6% to $13.65.
• Sequential Brands Group, Inc. SQBG shares rose 15.5% to $6.03. Sequential Brands reported Q2 results last week.
• Verrica Pharmaceuticals Inc. VRCA surged 15% to $9.84. A Form 4 filing filed with the SEC on Wednesday, August 19 showed that Manning Paul B bought 10,000 shares in the company.
• At Home Group Inc. HOME gained 13.4% to $19.03.
• Surface Oncology, Inc. SURF rose 13.2% to $6.95. Surface Oncology posted a Q2 loss of $0.44 per share last week.
• Resolute Forest Products Inc. RFP shares gained 13.3% to $4.19 as RBC Capital upgraded the stock from Sector Perform to Outperform and raised the price target from $4 to $5.5.
• KVH Industries, Inc. KVHI rose 12.8% to $8.82.
• Flux Power Holdings, Inc. FLUX gained 11.9% to $4.70 after dropping 17% on Tuesday Flux Power reported pricing of $10.8 million public offering last week.
• Target Corporation TGT rose 11.5% to $152.62 after reporting upbeat quarterly results. The company also reported Q2 comparable sales grew 24.3% and digital comparable sales grew 195%.
• Unum Therapeutics Inc. UMRX shares rose 11.3% to $3.0150. Unum Therapeutics released Q2 results last week.
• Avalon Globocare Corp AVCO gained 8.9% to $1.7422 after the company announced the commercialization and distribution agreement with Cellex for the coronavirus antibody rapid test kit.
• OneSmart International Education Group Limited ONE rose 5.7% to $5.73. OneSmart shares jumped over 30% on Tues after reporting Q3 results.
• Monopar Therapeutics Inc MNPR gained 5% to $5.85 after the company announced it partnered up with NorthStar and Aragen for the testing of the novel potential therapeutic doe severe coronavirus.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• BioMarin Pharmaceutical Inc. BMRN shares dipped 36.4% to $75.47 after the company received a Complete Response Letter from the FDA for valoctocogene voxaparvovec gene therapy for severe hemophilia A. Stifel downgraded Biomarin Pharmaceutical from Buy to Hold and lowered the price target from $127 to $100.
• Galapagos NV GLPG fell 24.7% to $141.55 after Gilead received a complete response letter from the FDA requesting data from two studies for Filgotinib before completing its review of the NDA and expressed concern about the benefit/risk profile. The two companies are collaborative partners in the global development and commercialization of Filgotinib in Rheumatoid Arthritis. Cantor Fitzgerald lowered the price target on the stock from $192 to $134.
• Greenpro Capital Corp. GRNQ fell 21.8% to $1.29. Greenpro Capital shares jumped 117% on Tuesday after the company announced plans to distribute twelve million shares of common stock of D'Swiss to GRNQ's shareholders.
• Vipshop Holdings Limited VIPS fell 20.1% to $19.08 after the company reported worse-than-expected Q2 results. The company also announced the CFO will be resigning for personal reasons.
• Eyenovia, Inc. EYEN fell 18.6% to $3.66 after the company announced a proposed common stock offering.
• MICT, Inc. MICT dropped 16.7% to $4.24. MICT shares jumped 46% on Tuesday after the company announced its subsidiary Micronet has received the first significant order for its SmartCam following a successful pilot trial with a leading global telematics provider.
• CLPS Incorporation CLPS fell 14.1% to $3.0507. On Tuesday, CLPS announced its strategic investment inGuangdong Huaqin Zhichuang Software Technology Co., Ltd.
• Qumu Corporation QUMU dipped 13.1% to $5.22.
• Jack Henry & Associates, Inc. JKHY fell 11.8% to $174.64 after the company issued weak FY21 forecast.
• comScore, Inc. SCOR shares dipped 11.7% to $2.80.
• Sabre Corp SABR fell 11.6% to $6.97 after the company reported a $250 million offering at $100 per share.
• Kamada Ltd. KMDA dropped 11.1% to $10.25. Kamada and Kedrion Biopharma reported results from a U.S. post-marketing pediatric trial of KEDRAB.
• Hudson Capital Inc. HUSN fell 9.7% to $0.4852 after climbing 13% on Tuesday..
• Sorrento Therapeutics, Inc. SRNE fell 9.6% to $11.10 as a reaction to the company firing its Chief Financial Officer Jiong Shao.
• Cree, Inc. CREE fell 8.7% to $62.51 after the company issued weak Q1 earnings guidance. JMP Securities and Roth Capital downgraded the stock.
• Abraxas Petroleum Corporation AXAS fell 8.5% to $0.1831. Abraxas Petroleum shares jumped around 16% on Tuesday after the company’s board determined to renew the strategic alternatives review announced last October.
• Sunworks, Inc. SUNW rose 7.3% to $0.9653 after jumping 27% on Tuesday. The Peck Co, last week, announced plans to buy Sunworks in a stock deal.
• India Globalization Capital, Inc. IGC fell 7.1% to $1.6902 after dropping 12% on Tuesday. India Globalization Capital, last week, said the FDA approved the initiation of the company's cannabinoid trial on Alzheimer's patients.
• LightInTheBox Holding Co., Ltd. LITB fell 7% to $2.6601 after the company reported second-quarter results. The company said it expects Q3 sales of $95 million to $110 million.
• Plymouth Industrial REIT, Inc. PLYM shares fell 7% to $12.85 after the company priced offering of 7.5 million shares of common stock at $12.85 per share.
• TJX Companies Inc TJX dropped 6% to $53.99 after the company reported worse-than-expected Q2 earnings. The company also announced it expects Q3 open-only comp-store sales to decrease in the range of 10%-20%.
• Adtalem Global Education Inc. ATGE fell 5.8% to $33.90 after reporting Q4 results.
• Marathon Patent Group, Inc. MARA fell 5.2% to $3.2316 after declining 8% on Tuesday. Marathon Patent, last week, announced it has entered into a long term purchase contract with Bitmain for the purchase of 10,500 next-generation Antminer S-19 Pro ASIC Miners.
• Forward Industries, Inc. FORD fell 5% to $1.6850. Forward Industries shares jumped around 30% on Tuesday after the company announced on Monday it has acquired Kablooe Design.
• Gilead Sciences, Inc. GILD fell 4% to $66.36 as it announced its application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis (RA) didn’t get the go-ahead from the United StatesFood and Drug Administration.